Search

Search Constraints

You searched for: Author/Creator Kuittinen, Outi

Search Results

1. 15‐year follow‐up of the Second Nordic Mantle Cell Lymphoma trial (MCL2): prolonged remissions without survival plateau. (5th July 2016)

2. Autograft cellular composition and outcome in NHL patients: results of the prospective multicenter GOA study. Issue 9 (28th July 2020)

3. Autologous stem cell transplantation in peripheral T-cell lymphoma: better mobilization of blood CD34+ cells is associated with improved survival. Issue 12 (14th October 2020)

4. Autologous stem cell transplantation in peripheral T-cell lymphoma: better mobilization of blood CD34+ cells is associated with improved survival. Issue 12 (14th October 2020)

5. Biological roles and prognostic values of the epithelial–mesenchymal transition‐mediating transcription factors Twist, ZEB1 and Slug in diffuse large B‐cell lymphoma. Issue 2 (27th November 2012)

6. CD34+ cell mobilization, blood graft composition, and posttransplant recovery in myeloma patients compared to non‐Hodgkinʼs lymphoma patients: results of the prospective multicenter GOA study. Issue 7 (24th April 2020)

7. Cell cycle regulation score predicts relapse‐free survival in non‐germinal centre diffuse large B‐cell lymphoma patients treated by means of immunochemotherapy. (3rd May 2013)

8. Constant pattern of relapse in primary central nervous lymphoma patients treated with high-dose methotrexate combinations. A Finnish retrospective study. (June 2015)

9. Detailed Long-Term Follow-Up of Patients Who Relapsed After the Nordic Mantle Cell Lymphoma Trials: MCL2 and MCL3. Issue 1 (21st January 2021)

10. Different chemokine profile between systemic and testicular diffuse large B-cell lymphoma. Issue 9 (29th July 2021)